KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Return on Assets: 2009-2025

Historic Return on Assets for Acadia Pharmaceuticals (ACAD) over the last 17 years, with Sep 2025 value amounting to 0.20%.

  • Acadia Pharmaceuticals' Return on Assets rose 7.00% to 0.20% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.20%, marking a year-over-year increase of 7.00%. This contributed to the annual value of 0.23% for FY2024, which is 33.00% up from last year.
  • As of Q3 2025, Acadia Pharmaceuticals' Return on Assets stood at 0.20%, which was up 8.44% from 0.19% recorded in Q2 2025.
  • Over the past 5 years, Acadia Pharmaceuticals' Return on Assets peaked at 0.21% during Q4 2024, and registered a low of -0.36% during Q4 2022.
  • Moreover, its 3-year median value for Return on Assets was 0.03% (2024), whereas its average is 0.02%.
  • Its Return on Assets has fluctuated over the past 5 years, first dropped by 13bps in 2022, then spiked by 37bps in 2024.
  • Quarterly analysis of 5 years shows Acadia Pharmaceuticals' Return on Assets stood at -0.24% in 2021, then dropped by 13bps to -0.36% in 2022, then grew by 27bps to -0.09% in 2023, then climbed by 30bps to 0.21% in 2024, then increased by 7bps to 0.20% in 2025.
  • Its Return on Assets was 0.20% in Q3 2025, compared to 0.19% in Q2 2025 and 0.20% in Q1 2025.